* Cross Country Healthcare Inc CCRN.OQ CCRN.O is
expected
to show a fall in quarterly revenue when it reports results on
February 22.
* The Boca Raton Florida-based company is expected to
report a
7.2% decrease in revenue to $594.567 million from $640.68
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
November 2 2022, for the period ended December 31, was for
revenue between 590.00 million and 600.00 million.
* Refinitiv's mean analyst estimate for Cross Country
Healthcare
Inc is for earnings of 89 cents per share. The company's EPS
guidance on November 2 2022, for the period ended December
31, was between 0.85 and 0.95
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cross
Country
Healthcare Inc is $41.5, above its last closing price
of $25.60.
The company's guidance on November 2 2022 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 590 million and 57
million.The company's guidance on November 2 2022 for the period
ended December 31 was for gross profit margin between 22.3% and
22.8%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.96 0.95 1.07 Beat 12.6
Jun. 30 2022 1.35 1.35 1.40 Beat 3.8
Mar. 31 2022 1.34 1.31 1.70 Beat 29.3
Dec. 31 2021 1.30 1.24 1.40 Beat 12.6
Sep. 0.34 0.34 0.61 Beat 77
30 2021
Jun. 30 2021 0.40 0.40 0.47 Beat 18.7
Mar. 31 2021 0.34 0.34 0.58 Beat 69.9
Dec. 31 2020 0.09 0.09 0.19 Beat 121.6
This summary was machine generated February 21 at 02:24 GMT.
All figures in US dollars unless otherwise stated